Opinion

Video

Addressing Unmet Needs and Emerging Agents

Jonathan Silverberg, MD, PhD, MPH, evaluates persistent unmet needs in the field and highlights promising new treatments currently under development.

Video content above is prompted by the following:

  • Despite the available treatment options, what are the remaining unmet needs or areas requiring further research and development in the management of disease states driven by type 2 inflammation?
  • What emerging agents in the pipeline are you most excited for?

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Videos
EHA 2025 Congress Recap | Image Credit: Venngage
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo